V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007698 | 240004759 | 1.58 | 75.6 | Not known (9) | null | 2016-03-04 | Bendamustine + prednisolone | N | N | 240034348 | BENDAMUSTINE |
| 240007699 | 240004760 | null | 62 | Adjuvant (A) | 2015-02-25 | 2015-02-27 | Carboplatin + Etoposide iv&po | Y | N | 240034350 | CARBOPLATIN + ETOPOSIDE |
| 240007700 | 240004761 | 1.6 | 59 | Disease modification (D) | 2017-05-15 | 2017-05-27 | AML Interim Guidelines FLA | 02 | N | 240034353 | NOT MATCHED |
| 240007701 | 240004762 | 1.68 | null | Palliative (P) | 2013-08-07 | 2013-08-07 | CHLORAMBUCIL + RITUXIMAB | N | N | 240034355 | CHLORAMBUCIL + RITUXIMAB |
| 240007702 | 240010647 | 1.66 | 49.8 | Curative (C) | null | 2017-04-14 | Chlorambucil | N | N | 240034356 | CHLORAMBUCIL |
| 240007703 | 240010647 | 1.6 | 84 | Adjuvant (A) | 2014-12-25 | 2015-01-24 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 240034356 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007704 | 240004763 | 1.79 | null | Neo-adjuvant (N) | 2015-02-09 | 2015-03-09 | INTERLACE TRIAL | 2 | N | 240034367 | INTERLACE TRIAL |
| 240007705 | 240004763 | 1.55 | null | Curative (C) | 2015-06-14 | 2015-06-14 | Bendamustine +/- Prednisolone | 1 | Y | 240034367 | BENDAMUSTINE |
| 240007706 | 240004764 | 1.58 | 53.2 | Neo-adjuvant (N) | 2013-04-24 | 2013-04-25 | Carboplatin + Etoposide IV 3 day | Y | Y | 240034370 | CARBOPLATIN + ETOPOSIDE |
| 240007707 | 240004765 | 1.61 | 68.3 | Curative (C) | 2013-04-19 | 2013-04-20 | Carboplatin + Etoposide iv&po | 2 | N | 240034371 | CARBOPLATIN + ETOPOSIDE |
| 240007708 | 240010649 | 1.72 | null | Palliative (P) | 2014-01-21 | 2014-02-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | null | 240034375 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007709 | 240010649 | 1.62 | null | Curative (C) | 2013-12-04 | 2013-12-04 | SMILE | N | N | 240034375 | TRIAL |
| 240007710 | 240004766 | 1.75 | 0 | Not known (9) | 2014-04-07 | 2014-04-09 | Chlorambucil | Y | Y | 240034382 | CHLORAMBUCIL |
| 240007711 | 240004767 | 1.64 | 75.2 | Neo-adjuvant (N) | 2017-05-29 | 2017-06-09 | INTERLACE TRIAL | 02 | N | 240034384 | INTERLACE TRIAL |
| 240007712 | 240010650 | null | 58.9 | Curative (C) | 2015-01-26 | 2015-02-19 | null | Y | null | 240034386 | NOT MATCHED |
| 240007713 | 240010650 | 1.6 | 56 | Adjuvant (A) | 2015-07-13 | 2015-07-19 | CARBOPLATIN | N | N | 240034386 | CARBOPLATIN |
| 240007714 | 240004768 | 1.61 | 67 | Palliative (P) | 2017-01-01 | 2017-01-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240034391 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007715 | 240004769 | 1.68 | 0 | Palliative (P) | 2013-04-20 | 2013-04-23 | Hydroxycarbamide | 2 | N | 240034392 | HYDROXYCARBAMIDE |
| 240007716 | 240004770 | null | null | Palliative (P) | 2015-10-02 | 2015-10-06 | Chlorambucil | N | N | 240034406 | CHLORAMBUCIL |
| 240007717 | 240004771 | 1.87 | 62 | Disease modification (D) | 2016-12-09 | 2016-12-31 | Bendamustine +/- Prednisolone | N | N | 240034408 | BENDAMUSTINE |
| 240007718 | 240004772 | 1.74 | 61 | Palliative (P) | null | 2015-11-17 | DA 3 + 10 | 2 | N | 240034409 | DA |
| 240007720 | 240004774 | 1.72 | 56.15 | Palliative (P) | 2017-12-20 | 2017-12-28 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | N | 240034415 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007721 | 240004774 | 1.62 | 95 | Palliative (P) | 2017-12-08 | 2017-12-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240034415 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007722 | 240004775 | 1.68 | 50.2 | null | 2016-06-15 | 2016-06-28 | Carboplatin + Etoposide IV 3 day | 02 | N | 240034418 | CARBOPLATIN + ETOPOSIDE |
| 240007723 | 240004776 | null | 108.4 | Curative (C) | 2016-10-06 | 2016-10-09 | INTERLACE TRIAL | N | N | 240034420 | INTERLACE TRIAL |
| 240007724 | 240004777 | 1.64 | 77 | Curative (C) | 2014-04-24 | 2014-04-24 | DA 3 + 10 | N | N | 240034422 | DA |
| 240007725 | 240004778 | 1.67 | 87.1 | Palliative (P) | 2013-01-20 | 2013-01-20 | Bendamustine +/- Prednisolone | null | null | 240034425 | BENDAMUSTINE |
| 240007726 | 240004778 | 1.62 | 0 | Palliative (P) | 2014-04-26 | 2014-05-14 | CARBOPLATIN | 2 | N | 240034425 | CARBOPLATIN |
| 240007727 | 240004779 | 1.69 | 60.7 | Palliative (P) | 2016-06-17 | 2016-06-20 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240034436 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007728 | 240004780 | 1.55 | 55.7 | Palliative (P) | 2014-10-10 | 2014-10-26 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240034447 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007729 | 240004781 | 1.74 | 40.7 | Curative (C) | 2017-06-22 | 2017-06-27 | INTERLACE TRIAL | N | N | 240034448 | INTERLACE TRIAL |
| 240007730 | 240004782 | 1.63 | 50 | Disease modification (D) | null | 2016-07-21 | R Chlorambucil | null | null | 240034450 | CHLORAMBUCIL + RITUXIMAB |
| 240007731 | 240004783 | 1.6 | null | Palliative (P) | 2016-11-11 | 2016-11-13 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | 240034453 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007732 | 240004784 | null | 55.9 | Curative (C) | 2014-08-26 | 2014-09-03 | Chlorambucil | null | N | 240034461 | CHLORAMBUCIL |
| 240007733 | 240004785 | 1.61 | 77.2 | Palliative (P) | 2017-07-23 | 2017-07-27 | Hydroxycarbamide | N | N | 240034466 | HYDROXYCARBAMIDE |
| 240007734 | 240004786 | 1.44 | 84.7 | null | 2017-01-13 | 2017-01-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240034471 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007735 | 240010653 | 1.73 | 67.5 | Disease modification (D) | 2016-04-02 | 2016-04-05 | Hydroxycarbamide | 02 | N | 240034473 | HYDROXYCARBAMIDE |
| 240007736 | 240004787 | 1.5 | 91 | Curative (C) | 2015-11-13 | 2015-11-28 | Carboplatin + Etoposide iv&po | 2 | N | 240034475 | CARBOPLATIN + ETOPOSIDE |
| 240007737 | 240004787 | null | 41.2 | Curative (C) | 2017-03-02 | 2017-03-14 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 240034475 | NOT MATCHED |
| 240007738 | 240013546 | 1.75 | 75 | Curative (C) | 2017-10-31 | 2017-11-14 | Carboplatin AUC 2 - 5 | N | N | 240034479 | CARBOPLATIN |
| 240007739 | 240004788 | 1.63 | 76.5 | Disease modification (D) | 2017-12-02 | 2017-12-10 | Bendamustine +/- Prednisolone | N | N | 240034483 | BENDAMUSTINE |
| 240007740 | 240010655 | 1.78 | 86 | Palliative (P) | 2013-08-19 | 2013-09-20 | Chlorambucil | 1 | N | 240034485 | CHLORAMBUCIL |
| 240007741 | 240010655 | 1.44 | 68 | Disease modification (D) | 2015-06-09 | 2015-06-10 | BENDAMUSTINE | N | N | 240034485 | BENDAMUSTINE |
| 240007742 | 240014936 | 1.71 | 77.5 | Curative (C) | 2016-01-09 | 2016-01-09 | Chlorambucil | 01 | N | 240034489 | CHLORAMBUCIL |
| 240007743 | 240004789 | 1.73 | 83.7 | Disease modification (D) | 2017-08-21 | 2017-08-22 | Hydroxycarbamide | N | N | 240034492 | HYDROXYCARBAMIDE |
| 240007744 | 240004789 | null | null | Palliative (P) | 2015-08-26 | 2015-08-26 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | 240034492 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007745 | 240004790 | null | 56.5 | Curative (C) | 2017-04-22 | 2017-04-24 | INTERLACE TRIAL | N | Y | 240034506 | INTERLACE TRIAL |
| 240007746 | 240004791 | 0 | 53 | Disease modification (D) | 2014-02-07 | 2014-04-02 | Chlorambucil | N | N | 240034510 | CHLORAMBUCIL |
| 240007747 | 240010657 | 1.67 | 79.6 | null | 2018-05-10 | 2018-05-10 | CHLORAMBUCIL + RITUXIMAB | 2 | N | 240034518 | CHLORAMBUCIL + RITUXIMAB |
| 240007748 | 240004792 | null | 51 | null | 2017-08-16 | 2017-09-02 | Carboplatin AUC 2 - 5 | N | N | 240034520 | CARBOPLATIN |